Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...

Background Whether inhaled corticosteroids (ICSs) reduce major adverse cardiovascular events (MACEs) in people with chronic obstructive pulmonary disease (COPD) is debated. Objectives To establish, ...

We have also provided a breakdown of new and recent movies streaming by platform, which could be helpful for those who want to know about all the new titles available on services like Disney+ ...

A new study suggests ... the only steroid-free treatment to offer prescribers clinically proven superiority over the most prescribed ICS/LABA combination in preventing COPD exacerbations.

India has reported over 15 cases of HMPV. Meanwhile, China attributed the rise in cases to improved detection methods in ...

1 Division of Pulmonary and Critical Care, Department of Internal Medicine, Tannourine Governmental Hospital, Batroun, Lebanon. 2 Division of Pulmonary and Critical Care, Department of Internal ...

If you have gone through and introduced your kids to all the classic movies of your younger days and want to find new family movies to stream, you’ve come to the right place. Right now ...

especially when the two classes of drugs are used together. Given the high level of opioid poisonings that also involve benzodiazepines – in 2020, they made up 14% of total opioid overdose ...

Verona Pharma's Ohtuvayre, a novel COPD treatment, achieved $36 million in Q4 sales, indicating strong market interest and unmet need for new therapies. Despite aggressive pricing, Ohtuvayre's ...

Verona Pharma is off to a promising start as it launches its first product, Ohtuvayre, a maintenance treatment for chronic obstructive pulmonary disorder (COPD). In 2024, Ohtuvayre generated sales ...

Temple Health has that certification. A combination of drugs has been used to control PAH. But a new drug, Winrevair, could change the landscape. "It's the first one that can actually fix the ...